Mechanisms of action Ezetimibe's inhibition of cholesterol absorption results in depletion of the cholesterol in chylomicrons, which in turn leads to diminished hepatic cholesterol and ...

Ezetimibe reduces LDL cholesterol levels, and niacin raises HDL cholesterol levels; however, no previous studies have described the use of these two drugs in combination. Jelesoff and colleagues ...

Ezetimibe is a drug that selectively inhibits cholesterol absorption and further reduces LDL-C when used in addition to statins. The ENHANCE trial is a randomized study aimed at studying the ...

Moreover, 44% of the patients who received ezetimibe had a history of percutaneous ... should trigger further investigation on the endocrine actions of these agents.

Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...